We identified the associations of GPRS and the GPR-TME classifier with the development and prognosis of STS, revealing their biological evidence and the molecular basis and an underlying mechanism across multi-omics levels, providing biological evidence in guiding personalized medicine approaches. This evidence concerns the gene ALDH18A1 and telomere syndrome.